Bioscience Reports · 2019 · 19 citations · 31 references
MedicineOncologyPathologyMetastasisMolecular OncologyNeoplasiaImmuno-oncology BiomarkersMalignant NeoplasmsOvarian CancerTumor-associated AntigensFigo StagingKaplan-meier Survival EstimatesLymphatic Metastasis BiomarkersLymphatic Metastasis PrognosisMalignant Ovarian TumorsMicroarray AnalysisPrognostic Factors AnalysisTissue Microarray Analysis
Abstract Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that has been reported to be associated with several malignant tumors. The present study aimed to evaluate its role in epithelial ovarian carcinoma (EOC). The mRNA levels of TSLP in human EOC samples and EOC cell lines were determined. Then, the expression of TSLP was examined in 144 clinical tissue microarray samples and correlated with clinicopathological factors. Finally, the correlation between TSLP overexpression and prognosis of EOC patients was analyzed. Our data show that mRNA levels of TSLP were significantly higher in EOC tissues and cell lines. Chi-square tests revealed that TSLP overexpression in EOC was significantly associated with age, histological type, Federation of Gynecology and Obstetrics (FIGO) stage, histological differentiation, pelvic involvement, and lymphatic metastasis. Kaplan–Meier survival analysis revealed that poor prognosis was significantly correlated with older age, advanced FIGO stage, poor histological differentiation, pelvic involvement, lymphatic involvement, or TSLP overexpression (P<0.05). Additionally, multivariate Cox regression analysis confirmed pelvic involvement and TSLP overexpression as independent prognostic factors for both overall and disease-free survival. Taken altogether, TSLP overexpression reflects a more malignant phenotype and TSLP may be a novel biomarker for EOC.
31
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Zoulfia Allakhverdi, Michael R. Comeau, Heidi K. Jessup et al. · The Journal of Experimental Medicine · 2007 · 783 citations · Full text
Lucia De Monte, Michele Reni, Elena Tassi et al. · The Journal of Experimental Medicine · 2011 · 692 citations · Full text
Medicine, Immunology, Oncology +15